Get 20% lifetime commission for referring investors to digrin.com
here.
GT Biopharma, Inc. (GTBP) Financials
GTBP Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 5.8 million | 2.2 million |
| March 31, 2026 | 10.0 million | 2.4 million |
| Dec. 31, 2025 | 8.1 million | 2.3 million |
| Sept. 30, 2025 | 4.3 million | 1.3 million |
GTBP Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -4.3 million | 46000 |
| March 31, 2026 | -2.5 million | 46000 |
| Dec. 31, 2025 | -4.0 million | 432000 |
| Sept. 30, 2025 | -3.7 million | 379000 |
GTBP Net Income
No data available :(
GTBP Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 5.0 million | - | - |
| March 31, 2026 | 8.9 million | - | - |
| Dec. 31, 2025 | 6.8 million | - | - |
| Sept. 30, 2025 | 2.6 million | - | - |
GTBP Shares Outstanding
GTBP Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 111000 | 3.5 million | - |
| March 31, 2026 | - | 413000 | 2.4 million | - |
| Dec. 31, 2025 | - | 1.4 million | 4.2 million | - |
| Sept. 30, 2025 | - | 634000 | 2.7 million | - |
GTBP Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
GTBP
Price: $7.03
52 week price:
Payout Ratio Range:
Earnings Per Share: 5.21 USD
P/E Ratio: 0.05
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 64789
Market Capitalization: 7.7 million